Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells
Clinical trial NCT02573896 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02573896
- Sponsor
- New Approaches to Neuroblastoma Therapy Consortium
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-14
- Primary completion
- 2026-12-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.